Navigation Links
Organ Donor Shortage Remains Obstacle for Would-Be Transplant Patients Despite Better Medicine
Date:2/4/2008

NEW YORK, Feb. 4 /PRNewswire/ -- There is a large and growing "treatment gap" between the number of patients worldwide who would benefit from an organ transplant and the number of organs available, a gap that is impacting transplant medicine markets, according to a new market research report from Kalorama Information, Organ Transplant Immunosuppressive Markets.

In the US, over 97,000 patients were on the United Network for Organ Sharing's list, while just 28,000 received a transplant. Other countries show similar gaps. This gap was first evident in 1998 and has increased every year.

Immunosuppressives, drugs which prevent the immune system from rejecting a new organ, may have become victims of their own success. Medicines such as Astella's Prograf and Roche's CellCept have reduced incidence of acute organ rejection and made transplantation a viable option in more cases, thus increased organ waiting lists. Kidney acute rejection rates alone decreased from 51% in 1996 to 13% eight years later as a result of these therapies. Over $5 billion worth of these drugs were sold in 2007.

"The pharmaceutical industry has created effective medications, and now the challenge is in the public policy arena," said Bruce Carlson, Publisher of Kalorama Information. "Awareness of the need for organ donation must be increased for the demand to be completely served. Volunteer efforts towards more organ donation have so far not been sufficient."

Despite the shortage, the study indicates that the marketplace for immunosuppressives will still grow at nearly five percent for the next five years due to a small increase in transplant operations and increased survival rates of patients who will require treatment for a longer period. But the study stresses that solving the donor shortage would lead to exponential growth in transplant medicine markets.

Organ Transplant Immunosuppressive Markets provides detailed statistics, market size and forecasts, trends and competitive analysis for kidney, liver, lung, heart and intestine transplants. This report can be purchased directly from Kalorama Information by visiting http://www.kaloramainformation.com/Organ-Transplant-Immunosuppressive-13995 27/

About Kalorama Information

Kalorama Information supplies the latest in independent market research for the life sciences and a full range of custom research services. For more information, contact Tom Ehart at 240-747-3014 or tehart@marketresearch.com, or visit http://www.KaloramaInformation.com.


'/>"/>
SOURCE Kalorama Information
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
2. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
3. Grammy Winner Marc Cohn to Perform for African AIDS Organization at Carolina HopeFest
4. Amicus Therapeutics to Present at the 26th Annual JPMorgan Healthcare Conference
5. Idenix Pharmaceuticals Provides Update on Hepatitis C Pipeline at JP Morgan Healthcare Conference
6. UCLA Program Aims to Revolutionize Kidney Transplants
7. Sexual Function Affected by Stem Cell Transplant According to Long-Term Study
8. Risks Associated With Face Transplants May Be Lower Than Previously Thought, ASPS Journal Review Suggests
9. Improved Cornea Surgery Technique Provides Enhanced Transplant Success
10. Allegheny General Hospital Performs First Liver Transplant
11. Pediatric Pulmonary Expert Comments on Study of Lung Transplants for Cystic Fibrosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... CLEMENTE, Calif. , June 24, 2016  American Respiratory Labs ... company, is now able to perform sophisticated lung assessments in patients, ... Technologies , Inc. Patients are no longer limited ... ndd,s EasyOne PRO ® , ARL patients like Jeanne R. of ... done in the comfort of her own home. ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
(Date:6/23/2016)... HOUSTON , June 23, 2016  MedSource ... platform as its e-clinical software solution of choice.  ... the best possible value to their clients by ... nowEDC.  The preferred relationship establishes nowEDC as the ... pricing for MedSource,s full-service clients.  "nowEDC has long ...
Breaking Medicine Technology:
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health ... of their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards ... at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to ...
(Date:6/24/2016)... ... 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out of ... verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ... raise to $12 an hour by 2020 and then adjusting it yearly to increase at ... the minimum wage, assure the wage floor does not erode again, and make future increases ...
(Date:6/24/2016)... Frederick, Maryland (PRWEB) , ... June 24, 2016 ... ... Mid-Atlantic Angels is actively feeding the Frederick area economy by obtaining investment capital ... support over the past 2½ years that have already resulted in more than ...
Breaking Medicine News(10 mins):